Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation
Satish Shanbhag1,2, Mitchell R Smith1, Robert VB Emmons21Department of Medical Oncology, Fox Chase Cancer Center, 2Division of Bone Marrow Transplantation, Temple University, Philadelphia, PA, USAAbstract: Mantle cell lymphoma (MCL) is a type of non-Hodgkins lymphoma (NHL) associated with poor progr...
Saved in:
Main Authors: | Satish Shanbhag, Mitchell R Smith, Robert VB Emmons |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2010
|
Subjects: | |
Online Access: | https://doaj.org/article/d68f3bca3b8a4460ae9101b261536de9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Some aspects of allogeneic stem cell transplantation in patients with myelodysplastic syndrome: advances and controversy
by: Blau O, et al.
Published: (2014) -
Hematopoietic stem cell transplantation for the management of follicular lymphoma
by: Chitra Hosing
Published: (2010) -
Hematopoietic stem cell transplantation
by: Eleftheria Hatzimichael, et al.
Published: (2010) -
Treatment of systemic sclerosis: potential role for stem cell transplantation
by: Wen Xiong, et al.
Published: (2009) -
Cat amniotic membrane multipotent cells are nontumorigenic and are safe for use in cell transplantation
by: Vidane AS, et al.
Published: (2014)